Orive M, Barrio I, Orive V M, Matellanes B, Padierna J A, Cabriada J, Orive A, Escobar A, Quintana J M
Research Unit, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain; Health Services Research on Chronic Patients Network (REDISSEC), Bilbao, Bizkaia, Spain.
Department of Applied Mathematics, Statistics and Operational Research, University of the Basque Country UPV/EHU, Leioa, Spain.
J Psychosom Res. 2015 Jun;78(6):563-8. doi: 10.1016/j.jpsychores.2015.03.003. Epub 2015 Mar 11.
Epidemiological evidence suggests an association between psychological factors and functional dyspepsia (FD). Yet few randomized controlled trials (RCTs) of psychological interventions have been conducted for FD. We conducted an RCT to evaluate the efficacy of psychotherapy among chronic FD.
One hundred fifty-eight consecutive patients with FD were randomized to medical therapy plus psychotherapy consisted in 8 group and 2 individual sessions focused on teaching techniques for coping with FD (intensive treatment (IT); n=76) or medical therapy alone (conventional treatment (CT); n=82). Patients completed validated self-reported questionnaires before and after the 10-week treatment and 6 months later. Linear mixed-effects models were used, in intention-to-treat analysis.
At the end of treatment period, statistically significant improvements were observed for IT compared with CT for dyspepsia-related quality of life (DRQoL). DRQoL mean changes of 6.09 and 3.54 were obtained in IT and CT patients, respectively (p=<0.0001); and SS mean changes of 11.55 and 4.57 were obtained in IT and CT patients, respectively (p=0.0013). Those improvements, measured by minimum clinically important difference (MCID), were clinically significant (DRQoL: 77% of the IT patients exceeded the MCID vs. the 45% of the CT; SS: 75% vs. 48%). Six months after treatment, those statistically significant improvements persisted for DRQoL (p=0.0067) and for SS (p=0.0405). Clinical improvements persisted for SS (63% vs. 41%).
These findings suggest that adding psychotherapy to standard medical therapy improves short-term outcomes in patients with FD and may have long-term effects as well. The cost-effectiveness of intensive therapy needs to be evaluated. Registration number and name of trial registry: NCT01802710.
流行病学证据表明心理因素与功能性消化不良(FD)之间存在关联。然而,针对FD的心理干预随机对照试验(RCT)却很少。我们开展了一项RCT以评估心理治疗对慢性FD的疗效。
158例连续的FD患者被随机分为接受药物治疗加心理治疗组(强化治疗(IT)组,共8次团体治疗和2次个体治疗,重点教授应对FD的技巧;n = 76)或仅接受药物治疗组(传统治疗(CT)组;n = 82)。患者在10周治疗前后及6个月后完成经过验证的自我报告问卷。采用意向性分析的线性混合效应模型。
在治疗期结束时,与CT组相比,IT组在消化不良相关生活质量(DRQoL)方面有统计学意义的改善。IT组和CT组患者的DRQoL平均变化分别为6.09和3.54(p =<0.0001);IT组和CT组患者的症状严重程度(SS)平均变化分别为11.55和4.57(p = 0.0013)。以最小临床重要差异(MCID)衡量,这些改善具有临床意义(DRQoL:77%的IT组患者超过MCID,而CT组为45%;SS:75% 对 48%)。治疗6个月后,DRQoL(p = 0.0067)和SS(p = 0.0405)的这些统计学意义的改善仍然存在。SS的临床改善持续存在(63% 对 41%)。
这些发现表明,在标准药物治疗基础上加用心理治疗可改善FD患者的短期结局,且可能也有长期效果。强化治疗的成本效益有待评估。试验注册号及试验注册名称:NCT01802710。